Tyrosine kinases and cancer therapy

被引：0
|
作者：
Gambacorti-Passerini, C [1 ]
机构：
[1] Univ Bicocca, Bicocca, Italy
来源：
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2006年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [41] Targeting Tyrosine Kinases and Autophagy in Prostate Cancer
    Kung H.-J.
    Hormones and Cancer, 2011, 2 (1): : 38 - 46
  • [42] Expression profile of tyrosine kinases in breast cancer
    Meric, F
    Lee, WP
    Sahin, A
    Zhang, HX
    Kung, HJ
    Hung, MC
    CLINICAL CANCER RESEARCH, 2002, 8 (02) : 361 - 367
  • [43] Receptor Tyrosine Kinases and Targeted Cancer Therapeutics
    Takeuchi, Kenji
    Ito, Fumiaki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (12) : 1774 - 1780
  • [44] PET Imaging of Receptor Tyrosine Kinases in Cancer
    Wei, Weijun
    Ni, Dalong
    Ehlerding, Emily B.
    Luo, Quan-Yong
    Cai, Weibo
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (08) : 1625 - 1636
  • [45] Receptor tyrosine kinases signaling in colorectal cancer
    Saucier, Caroline
    Bernier, Jimmy
    Chababi, Walid
    Galoul, Mohamed C.
    Landry, Melissa
    Pomerleau, Veronique
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 : S55 - S55
  • [46] Targeting tyrosine kinases in cancer: The second wave
    Baselga, Jose
    SCIENCE, 2006, 312 (5777) : 1175 - 1178
  • [47] Targeting receptor tyrosine kinases in gastric cancer
    Morishita, Asahiro
    Gong, Jian
    Masaki, Tsutomu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (16) : 4536 - 4545
  • [48] Targeting tyrosine-kinases in ovarian cancer
    Morotti, Matteo
    Becker, Christian M.
    Menada, Mario Valenzano
    Ferrero, Simone
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (10) : 1265 - 1279
  • [49] Bacterial tyrosine kinases: novel targets for antibacterial therapy?
    Cozzone, Alain J.
    TRENDS IN MICROBIOLOGY, 2009, 17 (12) : 536 - 543
  • [50] Targeting mutated tyrosine kinases in the therapy of myeloid leukaemias
    Banerji, L
    Sattler, M
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2004, 8 (03) : 221 - 239
12345